查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1840862

机器人切片检查设备市场按产品类型、技术、应用、最终用户和手术类型划分－2025-2032年全球预测

Robotic Biopsy Devices Market by Product Type, Technology, Application, End User, Procedure Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，机器人切片检查设备市场规模将成长 11.0661 亿美元，复合年增长率为 11.63%。

关键市场统计数据
基准年 2024 4.587亿美元
预计年份：2025年 5.1117亿美元
预测年份 2032 11.661亿美元
复合年增长率 (%) 11.63%

本书权威地概述了机器人技术、影像融合和程序创新如何融合，从而改变临床组织采样实践和相关人员的优先事项。

机器人切片检查解决方案结合了精准的机械结构、先进的影像处理技术和软体主导的引导，彻底改变了临床医生获取组织样本的方式，降低了操作差异，提高了诊断的准确性。过去十年间，微创技术与高解析度显像模式的融合，使机器人平台从小众研究仪器转变为满足日常诊断需求的实用临床工具。本文概述了该技术的发展现状，重点介绍了其关键的临床优势——更高的靶向精度、在特定情况下更短的手术时间以及更低的併发症率——同时也组装了更广泛应用该技术所涉及的运营和经济方面的考虑。

包括医院系统、诊断中心和门诊手术中心在内的相关人员，会从临床有效性、工作流程整合和投资报酬率等方面评估这些系统。由于机器人切片检查设备的临床价值与其引导成像技术密不可分，因此影像相容性和工作流程相容性尤其重要。同时，监管路径、报销环境和临床医生培训要求也在不断发展，以跟上设备创新的步伐。本引言为深入探讨技术变革、市场区隔动态、区域差异以及相关人员可用于调整其产品开发、市场推广和临床应用策略以适应影像引导组织取样新情势的策略槓桿奠定了基础。

对推动机器人组织采样技术普及和重新定义竞争优势的技术、临床和交付模式转变进行全面分析。

受技术成熟、临床需求和医疗服务模式转变的驱动，机器人切片检查设备领域正经历多重变革时期。影像引导和融合技术的进步使得在不同解剖区域进行更精准的标靶操作成为可能，而内建软体和机器学习则改进了针道规划并补偿了器官运动。这些技术进步与硬体的进步相辅相成。外形规格、模组化架构以及与多种成像系统相容的设备设计，降低了应用门槛，并扩大了其适用的临床环境范围。

同时，随着医疗服务从三级医院转移到门诊和流动医疗机构，医疗服务模式正变得日益分散化，这需要紧凑且经济高效的系统。以价值为导向的医疗模式正在奖励那些能够透过提高诊断产量比率和减少再次手术来显着降低后续成本的解决方案。供应链和製造趋势也在转变，强调弹性采购和本地组装以应对地缘政治风险。最后，随着同行评审的切片检查证据和真实世界经验检验了机器人活检的风险收益比，临床接受度正在不断提高，这加速了临床医生、支付方和医疗系统领导者之间关于适用场景和诊疗路径的对话。

对关税主导的成本压力和供应链调整将如何改变2025年机器人切片检查解决方案的采购、製造选择和采用时间进行实践评估

美国关税政策将于2025年生效，该政策的变化正对研发和销售机器人切片检查设备的公司的供应链和商业策略产生实际影响。进口关税若影响关键零件（例如精密致动器、影像相容支架和专用光学元件），则直接导致整套系统和耗材的到岸成本增加。因此，製造商和经销商面临三种选择：自行承担增加的成本、重新分配利润，或将增加的成本转嫁给医疗机构买家。

为此，一些战略调整正变得司空见惯。供应商正在重新评估筹资策略，并探索增加近岸外包和本地组装，以降低关税和运输中断的风险。与医院系统和诊断服务提供者的合约条款中越来越多地包含应对投入成本波动和库存缓衝的条款。对于规模较小的创新企业而言，不断上涨的进口成本正在收紧融资，这使得与成熟製造商建立战略伙伴关係关係和许可协议变得尤为重要，这些协议能够帮助它们扩大规模并实现采购多元化。最终，关税主导的成本效率正在减缓一些采购週期，并促使相关人员更加关注整体拥有成本。这表明，在评估新型机器人切片检查平台时，利害关係人越来越重视临床表现和采购的灵活性。

详细的細項分析展示了产品外形规格、影像技术、临床应用、终端使用者环境和手术类型如何决定临床适用性和商业化路径。

细分市场分析表明，产品设计、影像相容性、临床适应症、终端用户环境和手术类型决定了机器人切片检查系统的价值和实现方式。不同的产品类型定义了医院和诊所的特定应用场景。可携式机器人针对不同手术室之间的灵活性进行了优化，并对寻求紧凑型解决方案的门诊手术中心极具吸引力。因此，技术选择决定了工作流程和临床表现。 CT导引系统可提供更清晰的解剖结构讯息，便于定位深层器官；透视引导平台可实现某些介入手术的即时针头可视化；MRI引导解决方案在软组织造影和前列腺定位方面表现出色；超音波引导工具则为床边介入手术提供经济高效且无辐射的成像方式。

临床应用细分突显了应用场景的多样性和手术流程的复杂性。乳房切片通常优先考虑速度和患者舒适度；肾臟切片检查需要在移动的器官中精确控制穿刺深度；肝臟切片检查需要在穿刺路径和出血风险之间取得平衡；肺部切片检查需要在呼吸运动和复杂的胸腔解剖结构中进行导航；前列腺切片检查受益于MRI融合和更高的靶向精度。终端用户细分揭示了部署动态。门诊手术中心优先考虑便携性和快速週转；诊断中心重视吞吐量和与现有影像工作流程的整合；而医院则需要多功能性、无菌操作流程和全面的服务协议。粗针穿刺切片需要可靠的组织芯采样机制；细针穿刺活检需要精细的针头控制和细胞学方面的专业操作；真空辅助切片检查需要与抽吸机制和检体管理系统整合。这种细分观点指南产品蓝图、临床检验计划和销售活动，以确保与实际手术需求保持一致。

从区域观点分析美洲、欧洲、中东和非洲以及亚太地区的采用驱动因素、监管发展和商业化策略。

区域动态影响着机器人切片检查平台的普及率、监管趋势和商业化策略。在美国，医疗保健系统对支持早期癌症检测和微创诊断的创新技术需求强劲，并且已建立报销机制以加快医院的采购週期。欧洲、中东和非洲的情况更为复杂，欧盟的监管环境和各国支付方的政策与采购惯例筛检计画的增加、私立医院网路的扩张以及对影像基础设施的大力投资。然而，成熟市场（拥有高阶影像处理设备）和新兴市场（成本敏感度和可维护性是影响采购决策的主要因素）之间的普及程度存在差异。

在每个地区，临床证据的产生、在地服务能力和供应链韧性是决定产品持续应用的关键因素。区域监管时间表会影响产品上市顺序，而针对本地临床工作流程量身定制的培训和教育计画则能加速临床医生对产品的接受度。因此，製造商和经销商优先考虑因地制宜的商业化策略，这些策略反映了支付方奖励、医院采购週期以及支援设备长期运作和耗材供应所需的配送网路等方面的差异。

强调伙伴关係、临床证据、服务模式和智慧财产权优势的策略竞争动态，将决定机器人切片检查解决方案的长期领导地位。

机器人切片检查领域的竞争动态将由影像设备供应商、创新者和能够提供整合解决方案的临床相关人员之间的联盟所塑造。现有影像处理设备製造商利用其客户关係和平台专业知识提供与机器人相容的模组，而专注于机器人技术的公司则致力于人体工学介面、针头控制和软体主导。同时，灵活的新兴企业和学术衍生公司正在推出针对特定临床痛点的创新技术，例如针头转向、运动补偿和人工智慧辅助的标靶定位，迫使现有企业透过合作、授权或收购来应对。

商业性成功取决于展现临床价值并实施可扩展的服务模式。那些能够将可靠的临床证据与全面的售后支援、耗材供应链和培训服务结合的企业，往往能更快地渗透到医院系统和诊断网路中。智慧财产权状况和监管经验也会构成竞争壁垒，有利于那些拥有成熟合规团队和临床试验能力的企业。最终，竞争格局将奖励那些能够将卓越的工程技术与切实可行的商业化策略相结合的企业，从而弥合从前景广阔的原型产品到能够无缝集成到日常临床工作流程和医疗机构采购流程中的设备的鸿沟。

就产品架构、临床证据产生、供应链弹性以及商业模式提供实际的策略建议，以加速产品推广并保持竞争优势。

产业领导者应采取多维策略，在技术差异化和商业性可行性之间取得平衡。优先考虑平台模组化，以实现CT引导、透视、MRI引导和超音波引导环境的兼容性，从而拓展应用场景，减少对多种专用机壳的需求。投资开发支援手术规划、运动校正和决策支援的整合软体，以提高临床效用并缩短训练週期。同时，透过多元化采购、尽可能本地化组装以及降低关税和物流波动影响的库存策略，增强供应链韧性。

您的商业策略应强调基于证据的价值沟通。针对高优先级应用（例如切片检查和前列腺切片检查）进行有针对性的临床研究，同时在门诊手术和诊断中心等场所建立Proofpoint。提供灵活的购置方案，包括租赁和按需付费模式，以降低门诊病人机构的初始资本门槛。与影像设备製造商和医疗系统合作伙伴合作，共同开发检验的工作流程，以减少重复手术并提高诊断率。最后，投资扩充性的培训计画和远端支援能力，确保临床团队能够轻鬆采用新技术，这将加速技术应用，并实现这些系统所承诺的流程效率提升。

关键见解透过严谨的混合方法研究途径检验，该方法结合了专家访谈、监管和临床文献研究、专利审查和供应链评估。

本调查方法结合了对临床医生、采购负责人和技术专家的定性访谈，以及对监管申报文件、临床文献和公开设备註册资讯的系统性二次分析。访谈直接收集了放射科医生、介入医生、护理负责人和生物医学工程团队关于工作流程整合、临床医生偏好和采购限制等方面的见解。基于这些访谈，研究人员提出了关于推广障碍和价值驱动因素的假设，并用二手资料检验。二次分析回顾了同行评审的临床研究、操作指南、监管审批摘要和专利概况，以评估创新轨迹和实行技术的成熟度。

为补充定性分析结果，供应链和商业性分析考察了医院系统和门诊病人机构的供应商集中度、组件关键性以及采购惯例。此外，还进行了报销和政策审查，以了解影响医疗经济效益的支付方奖励和计费机制。在条件允许的情况下，透过跨资料来源的三角验证，检验了相关趋势，并为提出的策略建议奠定了坚实的基础。此方法优先考虑透明度和可重复性，详细记录了访谈通讯协定、辅助资讯纳入标准以及用于整合临床、技术和商业性洞察的分析框架。

本文简要总结了各项结论，重点阐述了机器人切片检查技术的临床应用前景、推广应用的先决条件以及将其普及应用所需的合作行动。

机器人切片检查设备在诊断流程中扮演日益重要的角色，精准的组织取样能够降低不确定性，并改善后续的临床决策。新兴技术，特别是影像融合、软体主导以及便于工作流程的硬体设计，正与医疗服务模式向微创、门诊病人治疗方向转变的趋势相契合。然而，其更广泛的应用取决于多种因素的共同作用，包括针对预期用途的可靠临床证据、与报销和采购惯例的一致性，以及能够降低地缘政治和关税风险的稳健的生产和供应链网络。

对于相关人员，协调一致的临床检验投资、与影像和服务供应商建立目标明确的伙伴关係，以及能够适应不同终端用户资金限制的灵活商业模式，才是未来的发展方向。当这些要素齐备时，机器人切片检查平台便能显着提升诊断效能和病患体验。随着技术生态系统的日益成熟，那些兼具严谨运作和临床同理心的机构，有望引领机器人活检技术从实验性应用过渡到常规操作。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 机器人切片检查系统整合了人工智慧驱动的即时成像和针头引导技术，以提高诊断准确性。
  • 全自动机械臂配备触觉回馈，可最大限度地减少复杂切片检查过程中的组织损伤。
  • 设备製造商与远端医疗平台建立策略伙伴关係，旨在实现全球远端机器人切片检查手术。
  • 将超音波、CT 和 MRI 结合的多模态感测器融合技术取得了进展，可用于精确的机器人针头定位。
  • 门诊诊所越来越多地采用机器人切片检查平台，以减少医院资源消耗和成本。
  • 开发一种紧凑、便携式可携式切片检查装置，用于农村和医疗资源匮乏地区的照护现场应用
  • 人工智慧机器人切片检查设备获监管部门核准，加速了新一代微创诊断解决方案的市场准入。
  • 将扩增实境视觉化工具整合到机器人切片检查系统中，以提高临床医生的导航能力和信心
  • 以订阅模式提供的机器人切片检查服务日益普及，该服务包含持续维护和软体升级。
  • 可客製化的一次性切片穿刺针数量增加，这些针筒专为单次使用而设计，旨在提高无菌性并减少交叉感染。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：按产品类型分類的机器人切片检查设备市场

  • 可携式机器人
  • 机械臂
  • 桌上型机器人

9. 按技术分類的机器人切片检查设备市场

  • CT导板
  • 透视指南
  • MRI 指南
  • 超音波引导

第十章 按应用分類的机器人切片检查设备市场

  • 乳房切片
  • 切片检查
  • 切片检查
  • 切片检查
  • 摄护腺切片检查

第十一章 按最终用户分類的机器人切片检查设备市场

  • 门诊手术中心
  • 诊断中心
  • 医院

第十二章：依手术类型分類的机器人切片检查设备市场

  • 核心针穿刺切片
  • 细针穿刺法
  • 真空辅助切片检查

第十三章：各地区机器人切片检查设备市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 机器人切片检查设备市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国机器人切片检查设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Medtech SA
    • Medrobotics
    • Biobot Surgical Pte Ltd
    • Mazor Robotics
    • iSYS Medizintechnik GmbH
    • Renishaw plc
    • Medtronic
    • Medical Device Business Services, Inc.
    • Stryker
    • Zimmer Biomet
Product Code: MRR-221461476FC5

The Robotic Biopsy Devices Market is projected to grow by USD 1,106.61 million at a CAGR of 11.63% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 458.70 million
Estimated Year [2025] USD 511.17 million
Forecast Year [2032] USD 1,106.61 million
CAGR (%) 11.63%

An authoritative overview of how robotics, imaging integration, and procedural innovation are converging to transform clinical tissue sampling practices and stakeholder priorities

Robotic biopsy solutions are reshaping how clinicians obtain tissue samples, combining precision mechanics, advanced imaging, and software-driven guidance to reduce variability and improve diagnostic confidence. Over the past decade, the convergence of minimally invasive procedural techniques and high-resolution imaging modalities has enabled robotic platforms to transition from niche research instruments to practical clinical tools that address everyday diagnostic needs. This introduction frames the technology landscape by highlighting the core clinical benefits-enhanced targeting accuracy, reduced procedure times in some settings, and potential decreases in complication rates-while acknowledging the operational and economic considerations that accompany broader adoption.

Stakeholders across hospital systems, diagnostic centers, and ambulatory surgical venues are evaluating these systems through the lenses of clinical efficacy, workflow integration, and return on investment. Imaging compatibility and workflow fit are especially critical because the clinical value of a robotic biopsy device is inseparable from the imaging technology that guides it. In parallel, regulatory pathways, reimbursement environments, and clinician training requirements are evolving to keep pace with device innovation. This introduction sets the stage for a deeper exploration of technological shifts, segmentation dynamics, regional variation, and strategic levers that stakeholders can use to align product development, go-to-market, and clinical adoption strategies with the emerging realities of image-guided tissue sampling.

A comprehensive analysis of the technological, clinical, and delivery-model shifts that are driving adoption and redefining competitive advantage in robotic tissue sampling

The landscape for robotic biopsy devices is undergoing several transformative shifts driven by technological maturation, clinical demand, and changing care delivery models. Advances in imaging guidance and fusion capabilities are enabling more accurate targeting across diverse anatomies, while embedded software and machine learning are improving needle path planning and compensating for organ motion. These technical improvements are complemented by hardware evolution: smaller form factors, modular architectures, and instruments designed for compatibility with multiple imaging suites lower barriers to adoption and expand the range of viable clinical settings.

Concurrently, care delivery is decentralizing as procedures migrate from tertiary hospitals into ambulatory and outpatient environments that demand compact, cost-efficient systems. The emphasis on value-based care is incentivizing solutions that demonstrably reduce downstream costs by improving diagnostic yield and reducing repeat procedures. Supply chain and manufacturing trends are also shifting, with an emphasis on resilient sourcing and localized assembly to manage geopolitical risks. Finally, clinical acceptance is strengthening as a growing body of peer-reviewed clinical evidence and real-world experience validates the risk-benefit profile of robotic-assisted biopsies, accelerating dialogues among clinicians, payers, and health system leaders about appropriate use cases and care pathways.

A practical assessment of how tariff-driven cost pressures and supply chain adjustments in 2025 are reshaping procurement, manufacturing choices, and adoption timelines for robotic biopsy solutions

Tariff policy changes in the United States introduced in 2025 have created tangible implications for the supply chains and commercial strategies of companies developing and distributing robotic biopsy devices. When import levies affect key components-precision actuators, imaging-compatible mounts, or proprietary optics-the immediate consequence is an increase in landed cost for finished systems and consumables. Manufacturers and distributors consequently face choices about absorbing incremental costs, reallocating margin, or passing increases to institutional buyers who are themselves under pressure to control procedural expenditures.

In response, several strategic adjustments have become common. Suppliers are reassessing procurement strategies and exploring nearshoring or expanded local assembly to reduce exposure to tariffs and transit disruptions. Contracting practices with hospital systems and diagnostic providers now more frequently include clauses that address input-cost volatility and inventory buffers. For smaller innovators, elevated import costs have tightened runway and increased the importance of strategic partnerships or licensing arrangements with established manufacturers that can offer scale and more diversified sourcing. Ultimately, tariff-driven cost effects slow some purchasing cycles and intensify emphasis on total cost of ownership, which certifies that stakeholder decisions now weigh both clinical performance and procurement resilience in evaluating new robotic biopsy platforms.

In-depth segmentation analysis showing how product form factor, imaging technology, clinical application, end-user environment, and procedure type determine clinical fit and commercialization pathways

Segmentation insights reveal how product design, imaging compatibility, clinical indication, end-user environment, and procedural technique collectively determine where and how robotic biopsy systems deliver value. Differences in product type create distinct hospital and clinic use cases; Portable Robots are optimized for flexibility across procedure rooms and are attractive to ambulatory surgical centers seeking compact solutions, Robotic Arms offer industrial-grade repeatability suited to high-volume hospital suites, and Table Mounted Robots integrate tightly with imaging tables to support precision work in radiology and hybrid operating rooms. Correspondingly, technology choices dictate workflow and clinical performance: CT Guided systems deliver excellent anatomical context for deeper organ targets, Fluoroscopy Guided platforms enable real-time needle visualization for specific interventional procedures, MRI Guided solutions excel in soft-tissue contrast and prostate localization, and Ultrasound Guided tools offer cost-effective, radiation-free imaging for bedside interventions.

Clinical application segmentation highlights the diversity of use cases and procedural complexity. Breast Biopsy procedures often prioritize speed and patient comfort, Kidney Biopsy requires precise depth control in a moving organ, Liver Biopsy balances access paths with bleeding risk, Lung Biopsy demands navigation through respiratory motion and complex thoracic anatomy, and Prostate Biopsy benefits from MRI fusion and enhanced targeting accuracy. End-user segmentation clarifies deployment dynamics: Ambulatory Surgical Centers prioritize portability and rapid turnover, Diagnostic Centers emphasize throughput and integration with existing imaging workflows, and Hospitals require versatility, sterilization pathways, and comprehensive service agreements. Procedure type further influences device design and consumable strategies; Core Needle Biopsy favors robust sampling mechanics for tissue cores, Fine Needle Aspiration demands delicate needle control and cytology-focused handling, and Vacuum Assisted Biopsy necessitates integration with aspirating mechanisms and specimen management systems. Together, these segmentation perspectives guide product roadmaps, clinical validation plans, and sales motions to ensure alignment with real-world procedural needs.

A regional perspective on adoption drivers, regulatory dynamics, and commercialization strategies across the Americas, Europe, Middle East & Africa, and Asia-Pacific

Regional dynamics shape adoption velocity, regulatory trajectories, and commercial strategies for robotic biopsy platforms. In the Americas, health systems exhibit strong demand for innovation that supports early cancer detection and minimally invasive diagnostics, paired with well-established reimbursement frameworks that expedite hospital procurement cycles; the United States remains a focal point for clinical trials, early adopter institutions, and a dense network of imaging and interventional specialists. Europe, Middle East & Africa present a more heterogeneous landscape where regulatory harmonization across the European Union and national payer policies coexist with variable infrastructure and procurement practices in other subregions; this diversity creates opportunities for tiered product offerings and partnerships with regional distributors that can manage local certification and service delivery requirements. Asia-Pacific demonstrates robust demand driven by growing screening programs, expanding private hospital networks, and proactive investments in imaging infrastructure, but adoption nuances differ between mature markets with high-end imaging suites and emerging markets where cost sensitivity and serviceability shape procurement decisions.

Across all regions, clinical evidence generation, localized service capabilities, and supply chain resilience are critical determinants of sustained adoption. Regional regulatory timelines influence product launch sequencing, while training and education programs tailored to local clinical workflows accelerate clinician acceptance. Manufacturers and distributors therefore prioritize region-specific commercialization strategies that reflect differences in payer incentives, hospital procurement cycles, and the distribution networks required to support long-term device uptime and consumable supply.

Strategic competitive dynamics emphasizing partnerships, clinical evidence, service models, and intellectual property advantages that determine long-term leadership in robotic biopsy solutions

Competitive dynamics in the robotic biopsy domain are shaped by alliances between imaging providers, device innovators, and clinical stakeholders that can deliver integrated solutions. Established imaging manufacturers are leveraging their customer relationships and platform expertise to offer robotics-compatible modules, while pure-play robotics firms concentrate on ergonomic interfaces, needle control, and software-driven guidance. At the same time, agile startups and academic spin-offs introduce focused innovations-needle steering, motion compensation, and AI-supported targeting-that address specific clinical pain points and compel incumbents to respond through collaboration, licensing, or acquisition.

Commercial success hinges on the ability to demonstrate clinical value and to implement scalable service models. Organizations that combine robust clinical evidence with comprehensive aftermarket support, consumable supply chains, and training services tend to achieve faster penetration in hospital systems and diagnostic networks. Intellectual property positions and regulatory experience also create barriers that favor players with established compliance teams and clinical trial capabilities. Ultimately, the competitive landscape rewards firms that can align engineering excellence with pragmatic commercialization tactics-crossing the gap from promising prototypes to devices that integrate seamlessly into daily clinical workflows and institutional procurement processes.

Actionable strategic recommendations for product architecture, clinical evidence generation, supply resilience, and commercial models to accelerate adoption and sustain competitive differentiation

Industry leaders should adopt a multi-dimensional strategy that balances technological differentiation with commercial pragmatism. Prioritize platform modularity to enable compatibility across CT Guided, Fluoroscopy Guided, MRI Guided, and Ultrasound Guided environments, which increases addressable use cases and reduces the need for multiple, specialized chassis. Invest in integrated software that supports procedural planning, motion compensation, and decision support to raise clinical utility while shortening training curves. At the same time, strengthen supply chain resilience through diversified sourcing, localized assembly where feasible, and inventory strategies that mitigate tariff and logistics volatility.

Commercial strategies should emphasize evidence-based value communication. Develop targeted clinical studies across prioritized applications-such as Lung Biopsy and Prostate Biopsy-while creating proof points for settings including Ambulatory Surgical Centers and Diagnostic Centers. Offer flexible acquisition options, including leasing and pay-per-use models, to lower initial capital barriers for outpatient facilities. Collaborate with imaging manufacturers and health system partners to co-develop validated workflows that demonstrate reductions in repeat procedures or improved diagnostic yield. Finally, invest in scalable training programs and remote support capabilities so clinical teams can adopt new technologies with confidence, thereby accelerating uptake and realizing the procedural efficiencies these systems promise.

A rigorous mixed-methods research approach combining expert interviews, regulatory and clinical literature review, patent analysis, and supply chain assessment to validate key insights

The research approach combines primary qualitative engagement with clinicians, procurement leaders, and technical experts alongside a systematic secondary review of regulatory filings, clinical literature, and publicly available device registries. Primary interviews provided first-hand perspectives on workflow integration, clinician preferences, and procurement constraints from radiologists, interventionalists, nursing leadership, and biomedical engineering teams. These engagements informed hypotheses about adoption barriers and value drivers that were then tested against secondary evidence. Secondary analysis included a review of peer-reviewed clinical studies, procedural guidelines, regulatory clearance summaries, and patent landscapes to assess innovation trajectories and the maturity of enabling technologies.

Supplementing qualitative insights, supply chain and commercial analyses examined supplier concentration, component criticality, and procurement practices across hospital systems and outpatient facilities. Reimbursement and policy reviews were conducted to understand payer incentives and billing mechanisms that affect procedural economics. Where possible, triangulation across data sources validated trends and provided a robust foundation for the strategic recommendations presented. The methodology prioritizes transparency and reproducibility by documenting interview protocols, inclusion criteria for secondary sources, and analytic frameworks used to synthesize clinical, technical, and commercial findings.

A concise concluding synthesis emphasizing the clinical promise, adoption prerequisites, and coordinated actions required to mainstream robotic biopsy technologies

Robotic biopsy devices are poised to play an increasingly important role in diagnostic pathways where precision tissue sampling reduces uncertainty and improves downstream clinical decision-making. Emerging technical capabilities-particularly in imaging integration, software-driven guidance, and workflow-friendly hardware designs-are aligning with shifts in care delivery that favor minimally invasive, outpatient-friendly interventions. However, broader adoption will depend on a confluence of factors: credible clinical evidence across targeted applications, alignment with reimbursement and procurement practices, and resilient manufacturing and supply networks that mitigate geopolitical and tariff-related risks.

For stakeholders, the path forward involves coordinated investment in clinical validation, purposeful partnerships with imaging and service providers, and flexible commercial models that address the capital constraints of a diverse set of end users. When these elements come together, robotic biopsy platforms can deliver measurable improvements in diagnostic performance and patient experience. As the technology ecosystem matures, organizations that combine operational rigor with clinical empathy will lead the transition from experimental adoption to routine procedural practice.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of AI-driven real-time imaging and needle guidance in robotic biopsy systems for enhanced diagnostic accuracy
  • 5.2. Emergence of fully automated robotic arms with haptic feedback to minimize tissue damage during complex biopsies
  • 5.3. Strategic partnerships between device manufacturers and telemedicine platforms to enable remote robotic biopsy procedures globally
  • 5.4. Advancement in multi-modal sensor fusion technologies combining ultrasound, CT, and MRI for precise robotic needle positioning
  • 5.5. Increasing adoption of robotic biopsy platforms in outpatient clinics to reduce hospital resource utilization and costs
  • 5.6. Development of compact portable robotic biopsy units for point-of-care applications in rural and underserved regions
  • 5.7. Regulatory approvals of AI-enabled robotic biopsy devices accelerating market entry of next-gen minimally invasive diagnostic solutions
  • 5.8. Integration of augmented reality visualization tools within robotic biopsy systems to improve clinician navigation and confidence
  • 5.9. Growth in subscription-based service models offering robotic biopsy as a service with continuous maintenance and software upgrades
  • 5.10. Rise of customizable disposable biopsy needle cartridges designed for single-use to enhance sterility and reduce cross contamination

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Robotic Biopsy Devices Market, by Product Type

  • 8.1. Portable Robots
  • 8.2. Robotic Arms
  • 8.3. Table Mounted Robots

9. Robotic Biopsy Devices Market, by Technology

  • 9.1. CT Guided
  • 9.2. Fluoroscopy Guided
  • 9.3. MRI Guided
  • 9.4. Ultrasound Guided

10. Robotic Biopsy Devices Market, by Application

  • 10.1. Breast Biopsy
  • 10.2. Kidney Biopsy
  • 10.3. Liver Biopsy
  • 10.4. Lung Biopsy
  • 10.5. Prostate Biopsy

11. Robotic Biopsy Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Diagnostic Centers
  • 11.3. Hospitals

12. Robotic Biopsy Devices Market, by Procedure Type

  • 12.1. Core Needle Biopsy
  • 12.2. Fine Needle Aspiration
  • 12.3. Vacuum Assisted Biopsy

13. Robotic Biopsy Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Robotic Biopsy Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Robotic Biopsy Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Medtech SA
    • 16.3.2. Medrobotics
    • 16.3.3. Biobot Surgical Pte Ltd
    • 16.3.4. Mazor Robotics
    • 16.3.5. iSYS Medizintechnik GmbH
    • 16.3.6. Renishaw plc
    • 16.3.7. Medtronic
    • 16.3.8. Medical Device Business Services, Inc.
    • 16.3.9. Stryker
    • 16.3.10. Zimmer Biomet

LIST OF FIGURES

  • FIGURE 1. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. ROBOTIC BIOPSY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. ROBOTIC BIOPSY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ROBOTIC BIOPSY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PORTABLE ROBOTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PORTABLE ROBOTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PORTABLE ROBOTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PORTABLE ROBOTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PORTABLE ROBOTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PORTABLE ROBOTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY ROBOTIC ARMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY ROBOTIC ARMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY ROBOTIC ARMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY ROBOTIC ARMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY ROBOTIC ARMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY ROBOTIC ARMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TABLE MOUNTED ROBOTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TABLE MOUNTED ROBOTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TABLE MOUNTED ROBOTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TABLE MOUNTED ROBOTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TABLE MOUNTED ROBOTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TABLE MOUNTED ROBOTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY CT GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY CT GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY CT GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY CT GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY CT GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY CT GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY FLUOROSCOPY GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY FLUOROSCOPY GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY FLUOROSCOPY GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY FLUOROSCOPY GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY FLUOROSCOPY GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY FLUOROSCOPY GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY MRI GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY MRI GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY MRI GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY MRI GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY MRI GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY MRI GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY BREAST BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY BREAST BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY BREAST BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY BREAST BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY KIDNEY BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY KIDNEY BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY KIDNEY BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY KIDNEY BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY KIDNEY BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY KIDNEY BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY LIVER BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY LIVER BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY LIVER BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY LIVER BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY LIVER BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY LIVER BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY LUNG BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY LUNG BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY LUNG BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY LUNG BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY LUNG BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY LUNG BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROSTATE BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROSTATE BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROSTATE BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROSTATE BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROSTATE BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROSTATE BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. AMERICAS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 127. AMERICAS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 129. AMERICAS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 131. AMERICAS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 133. AMERICAS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. NORTH AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. NORTH AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 142. NORTH AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 144. NORTH AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 146. NORTH AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 148. NORTH AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. LATIN AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. LATIN AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 154. LATIN AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 156. LATIN AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 158. LATIN AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. LATIN AMERICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. MIDDLE EAST ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. MIDDLE EAST ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 190. MIDDLE EAST ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 192. MIDDLE EAST ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 194. MIDDLE EAST ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. MIDDLE EAST ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 202. AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 203. AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 204. AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 205. AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 206. AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 207. AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. AFRICA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. ASEAN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. ASEAN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. ASEAN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. ASEAN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. ASEAN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 228. ASEAN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 229. ASEAN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. ASEAN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. ASEAN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. ASEAN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. ASEAN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. ASEAN ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. GCC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GCC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GCC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. GCC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. GCC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 240. GCC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 241. GCC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. GCC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 243. GCC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. GCC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. GCC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. GCC ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPEAN UNION ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPEAN UNION ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPEAN UNION ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPEAN UNION ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPEAN UNION ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPEAN UNION ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. BRICS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. BRICS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. BRICS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. BRICS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. BRICS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 264. BRICS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 265. BRICS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. BRICS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. BRICS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. BRICS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. BRICS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. BRICS ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. G7 ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. G7 ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. G7 ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. G7 ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. G7 ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 276. G7 ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 277. G7 ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. G7 ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 279. G7 ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. G7 ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. G7 ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. G7 ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. NATO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. NATO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. NATO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. NATO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. NATO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 288. NATO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 289. NATO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. NATO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 291. NATO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 292. NATO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 293. NATO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. NATO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. UNITED STATES ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. UNITED STATES ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. UNITED STATES ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 300. UNITED STATES ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 301. UNITED STATES ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. UNITED STATES ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 303. UNITED STATES ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. UNITED STATES ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. UNITED STATES ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. UNITED STATES ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 307. CANADA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. CANADA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 309. CANADA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 310. CANADA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 311. CANADA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 312. CANADA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 313. CANADA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 314. CANADA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 315. CANADA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. CANADA ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. MEXICO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 318. MEXICO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 319. MEXICO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 320. MEXICO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 321. MEXICO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 322. MEXICO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 323. MEXICO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 324. MEXICO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 325. MEXICO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 326. MEXICO ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 327. BRAZIL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 328. BRAZIL ROBOTIC BIOPSY DEVICES MARKET SIZE, BY P